International Business Environment: A Case Study Of Ego Pharmaceuticals

Ego Pharmaceuticals

Discuss about the International Business Environment.

Generally, in the context of this research study, Ego Pharmaceuticals is chosen organization as Australian Pharmaceutical Company in order to achieve the aims/objectives and goals associated with the research study. Moreover, it is expected that, the company want to expand its business operations by entering into a global market such as China and South Africa. Additionally, this research study would also provide an overview about the different risks or issues or challenges that may be faced by the company in both markets. On the other hand, it would also offer description about the market opportunities available for the Ego Pharmaceuticals in both China and South Africa Market. Furthermore, based on the identified risks and available opportunities in the market, a best market/country among the China and South Africa would be selected with proper justification. Along with this, different kinds of market entry strategies would be discussed which one best strategy would be recommended to the company in order to enter into a most suitable market. Finally, the potential advantages and disadvantages of the selected market entry strategy would also be analysed. 

In the Australian Health care and Pharmaceutical industry, Ego Pharmaceuticals is considered one of the most ethical, trusted, and leading Australian Pharmaceutical Company. Moreover, it is found that, it is one of the largest and biggest drug manufacturing companies of the nation that produce and manufactures a wide range of pharmaceutical medicines. It is a privately held Pharmaceutical multinational skin care company that has business operations in different nations including Singapore, Hong Kong and the United Kingdom, Bahrain, Kuwait, Qatar, United Arab Emirates, Egypt and Saudi Arabia. But, it still now, it has not business in both China and South Africa (Ego Pharmaceuticals, 2016).         

Along with this, it is also accessed that, it is producing skincare products from the last sixty years. This company was developed by chemist Gerald Oppenheim in the year1953 in Melbourne, Australia. The company is also producing dermatological products for the people those facing skin related diseases. At the same time, it is analysed that, currently company is providing a wide range of skin care products in more than 11 nations of the world (Ego Pharmaceuticals, 2016).       

Risks and Opportunities in South Africa and China 

Fundamentally, commercial, country, financial and cross cultural risks etc are four sorts of risks confronted by an organization when it goes into global market. These dangers adversely influence the business operations, methodologies, techniques, piece of the overall industry, level of incomes, and benefit of an organization into the global market. In addition, it is essential for the new organization to get to capability of another nation by leading risks and open opportunities analysis.  

Risks and Opportunities in South Africa and China

Commercial Risks: It is also known as business risks that affect the overall business operations of a company. Moreover, it is sorts of risk that happens from the potential misfortunes emerging from the exchanging accomplices or the business sector. Be that as it may, in the China, there are less business risks by contrasting with South Africa. For instance, China had built up a considerable measure of free exchange concurrences with the Australia and solid business relations exits among these two. Interestingly, there is absence of such business contrast among the South Africa and Australia (Deloitee, 2013).     

Currency /Financial Risks: As contrast with South Africa, there would be less monetary risks accessible in the adjustments in the China market as a result of high genuine GDP rate. Additionally, the general financial and political circumstance of the China is solid by contrasting with South Africa so the organization ought to enter in the Chinees pharmaceutical industry (Yates, 2015).

Country Risks: These risks incorporate political danger, swapping scale hazard, financial danger, sovereign hazard and exchange risk. For case, the political and financial environment of the China is exceedingly steady and successful as contrast with South Africa because of accessibility of strict and strong business rules, laws, controls, and measures. Interestingly, the both political and financial environment of South Africa is not solid and powerful as contrast with China because of hole in administrative arrangements. Subsequently, there is less nation dangers in the China as contrast with South Africa (Completion Commission South Africa, 2015).

Cross-Cultural Risks: As with the most noteworthy populace, China is the biggest nation in the worldwide world with a populace of 1.357 billion and this is expanding quickly step by step. Interestingly, the number of inhabitants in South Africa is rough 52.98 million. This extraordinary distinction demonstrates that the Chinees populace is exceedingly expanded as contrast with South Africa. In China, there is diverse populace with various needs, needs and request that may influence the achievement and development of an organization in the country. Similarly, Chinese society is very mind boggling as contrast with South Africa so there are more prominent culturally diverse dangers exits in China (Impact Rx, 2015).

There are a lot of opportunities and benefits available both in China and South Africa. There are a ton of opportunities and advantages accessible both in China and South Africa. The pharmaceutical business sector or industry of South Africa is little as contrast with China so new organization can without much of a stretch focus on their clients for their item. There is no tight rivalry in the business sector and organizations can without much of a stretch grow business in the country (Moomaw, Olson, McLean, & Applegate, 2009).

Justification for the Chosen Country

Then again, the Pharmaceutical environment is creative and steady that can help new organization to enhance their level of benefit.  In the meantime, it is found that, there are no strict business rules for the new organizations inside the South Africa. Alongside this, it is gotten to that; there is absence of eco-accommodating wellbeing approaches created by the legislature. Interestingly, there are a considerable measure of business open doors and degree accessible in the China market as contrast with South Africa in light of world’s biggest and greatest business sector and economy. Then again, the developing focus of China is on advancement (KPMG, 2011).

Furthermore, the business sector of China is deal with higher-end customer products and services. Moreover, imaginative and strong business arrangements, laws, tenets, and directions are planned and created by the administration of China. This greatest opportunity accessible in the business sector of China is accessibility of prepared and very much talented representatives or workforce. Also, there are lessened rates of Tariffs and taxes with an expansive number of clients (Pharmaceutical & Life Sciences, 2016).

The new organization can take the upsides of accessibility of assets at the less expensive rate or cost. In the meantime, it is found that, in the China, low work costs, and solid political and financial structure are alternate favourable circumstances of this business sector. Chinese Business Etiquette and Culture can bolster another organization to extend its business in country adequately and effortlessly. At long last, there is additionally accessibility of various Large and little money related organizations and budgetary establishments (Deloitee, 2014).                

In light of the recognized risks, and opportunities, it is proposed that Ego Pharmaceuticals ought to enter and grow their business in China not in South Africa. It is on account of, there is more noteworthy and abnormal state of risks and difficulties exits in the business sector of South Africa as analyses to China. In addition, as contrast with South Africa, a considerable measure of business opportunities are accessible in the Chinees market that can be picked up by the Ego Pharmaceuticals keeping in mind the end goal to grow the business. Additionally, it is likewise found that, the political, financial, social, technical and legitimate environment of the China is stronger than South Africa. In this way, it is prescribed that; the organization ought to go for China to grow the business operations. In the meantime, it is likewise found that, in the South Africa, there is a frail strategy environment and restricted administrative backing for the Pharmaceuticals organizations. Conversely, in China, there is a solid strategy for such organizations and appropriate backing is given by the legislature to the organizations so as to develop and extend the business (Bioassociate, 2012).

Also, the Pharmaceutical business sector of the China is bigger and greatest as contrast with South Africa so there are more opportunities accessible in the Chinees market for the Pharmaceuticals organizations. Conversely, inside the Pharmaceuticals business division of the South Africa, there is a gap among the authorization limits and administrative system that may influence the achievement of the organization in the business sector. Then again, as contrast with China, in South Africa, there are setbacks in capital and aptitudes. Alongside this, China is one of the greatest and most populated nations in the worldwide world (National Industry Program, 2016).

 Besides, the Pharmaceutical segment of the China is likewise working exceptionally well and quick with quickest developing rate of economy and the financial and political structure of the country is powerful. Thus, it is recommended that, Ego Pharmaceuticals ought to enter and grow their business in China as contrast with South Africa keeping in mind the end goal to take the advantages of greatest and biggest business sector of the world (Strategy& , 2014).

It is likewise fundamental for the Ego Pharmaceuticals to choose a best market entry technique by investigating and getting to the business environment of China business sector. In this way, so as to pick a best technique, the organization would break down the monetary reconciliation between Australia and China. In addition, the organization would likewise need to investigate both the political and legitimate environment of the China.

Degree of Economic Integration: The financial incorporation among the China and Australia is at the territorial level which is set apart in the level of the development of middle of the road products bargain, intraregional exchange, and harmonization between incoherent parts of the assembling methods in the distinctive business areas. Then again, an unhindered commerce understanding is likewise exits and created among the Australia and China with a specific end goal to lessen exchange obstructions. In the meantime, it is likewise investigated that, in the year 2014, China is the greatest and biggest exchanging accomplice of China.

For instance, the representing 23 for each penny of Australia's two-way exchange, the second year reciprocal exchange values have surpassed A$150 billion. Similarly, China is the greatest and biggest fare market (A$98 billion) and wellspring of imports (A$54 billion). Similarly, China is the biggest shipper and exporter of the Australia that demonstrates solid business connections among these two countries. In the present time, Australia is likewise upgrading its two-path exchange with China to enhance its financial circumstance. Subsequently, it can be said that, there is an abnormal state of financial mix among the China and Australia (Xiong, Yamada, & Terano, 2015).

Monetary Environment of China: The financial environment of China is extremely solid as contrast with different countries of the worldwide world. For instance, the new outside organizations may take the advantages of weaker swapping scale and successfully extend the business in the country by enhancing their piece of the overall industry. Notwithstanding this, the monetary change made by the China from the most recent couple of years had made an appealing and strong goal speculators and exporters. In addition, there is a fast change in the GDP rate of China from the most recent 10 years. For instance, from the most recent ten decades, the GDP of China had extended by a normal 10% p.a. Conversely, the value business sector of the country is as of now experienced the sharp downturn. Be that as it may, China is utilizing a few methodologies as a part of request to manage this downturn in the value market. This is advantageous for the speculators and in addition new organization that need to grow the business in China (Pacific Bridge Medical, 2014).  

Political Environment of China: It is analysed to that; the political atmosphere of China is additionally exceptionally solid and successful. For instance, as per the World Bank, China is the second positioned base quartile of economies for three measurements of administration including absence of brutality, political solidness, solid law standards, and control of defilement. Moreover, CPSC (Central Politburo Standing Committee) is the most persuasive and most elevated basic leadership body in the country (Nanda, & Kumar, 2012).

Today, it is more critical and significant for the organizations or business firms to distinguish and picked a best market entry methodology keeping in mind the end goal to extend the business and go into the worldwide bazaar. For instance, there are various types of market entry technique, for example, Greenfield Investments, Piggybacking, Turnkey Projects, Merger, Acquisition, Partnering, Joint venture, Franchising, Licensing, direct trading and so forth. Every one of these techniques might be utilized by Ego Pharmaceuticals as a part of request to grow the business into the China. Thus, it is more thorough for the Ego Pharmaceuticals to break down and select a best market section methodology keeping in mind the end goal to go into the Chinese business sector or Pharmaceutical industry (Mitrev, & Culpepper, 2012).

Then again, it can be said that taking into account the level of monetary coordination, political and financial environment, and Joint venture would be a standout amongst the most profitable, dynamic, viable and best market entry strategy as contrast with others for the Ego Pharmaceuticals keeping in mind the end goal to enhance and grow business in the Chinese business sector (Thoo, 2013). For instance, as indicated by this technique, Ego Pharmaceuticals would create and make business plan with the Chinees Pharmaceutical organizations by consenting to pool their assets with the end goal of fulfilling a particular assignment. Furthermore, by utilizing this methodology, Ego Pharmaceuticals can likewise adequately grow the business in the China and make most extreme benefit viably. For instance, dangers and in addition benefits would be shared similarly by both the organizations in the business sector. Similarly, Ego Pharmaceuticals can have the capacity to build its business limit and get to more noteworthy assets viably (Moses, Moore, Pleasant, & Vest, 2011).

Furthermore, Joint venture would likewise permit the home organization to development and extend business operations in the host nation without borrowing stores. Along these lines, it would be less demanding for Ego Pharmaceuticals to set up a solid nearness in the China advertise and create greatest benefit and income successfully. Moreover, various types of unmistakable and impalpable advantages can likewise be picked up by Ego Pharmaceuticals through joint venture. For instance, such advantages incorporates: bigger business sector achieve, Barriers to rivalry, shorter expectation to absorb information, new income streams, upgraded believability, item and licensed innovation additions, Expertise and learning pick up (Roncoroni, Fusai, & Cummins, 2015). Henceforth, keeping in mind the end goal to increase such advantages, Ego Pharmaceuticals would utilize Joint venture as a business sector passage technique to enter and grow the business in China. But, in order to adopt this, the company has to develop long term relations with other companies in the Chinees market and spend much more time and investment (Cullen, & Parboteeah, 2010).

On the premise of above examination, it is compressed and proposed that, Ego Pharmaceuticals ought to enter and extend its business in China not in South Africa by utilizing joint venture market entry mode. In addition, it is likewise imperative for an organization to go into worldwide business sector to get to the current political, financial, and social environment. At last, it can be presumed that, various types of dangers/difficulties and open doors are ways out in the worldwide environment.

References

Bioassociate, 2012, Pharmerging Market: China- the next major innovative Pharma Market, viewed 22 September 2016, https://china.nlambassade.org/binaries/content/assets/postenweb/c/china/zaken-doen-in-china/sectoren/life-sciences/bioassociate-pharmerging-markets-china-2012.pdf

Completion Commission South Africa, 2015, Role of Competition in the Pharmaceutical Sector and its Benefits for Consumers. viewed 22 September 2016, https://unctad.org/meetings/en/Presentation/CCPB_7RC2015_RTPharma_SouthAfrica_en.pd

Cullen, J.B, & Parboteeah, KP, 2010, International Business: Strategy and Multinational Company, pp. 3-33.

Deloitee, 2013, Corruption Risks in Chinese Pharmaceutical Market, viewed 22 September 2016, https://www2.deloitte.com/content/dam/Deloitte/cn/Documents/finance/deloitte-cn-fas-corruption-risk-chinese-pharmaceutical-mkt-en-150813.pdf

Deloitee, 2014, 2015 life sciences outlook South Africa, viewed 22 September 2016, https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2015-life-sciences-report-south-africa.pdf

Ego Pharmaceuticals, 2016, About Us, viewed 22 September 2016, https://www.egopharm.com/

Impact Rx, 2015, A review of the South African Pharmaceutical landscape, viewed 22 September 2016, https://www.utipharma.co.za/documents/198965/199128/UTi+November+2015+-+South+Africa+V1.pdf/c9c979e4-41ce-4d2c-94dc-e24f5d8c1b43

KPMG, 2011, China’s Pharmaceutical Industry, viewed 22 September 2016, https://www.kpmg.com/cn/en/issuesandinsights/articlespublications/documents/china-pharmaceutical-201106-2.pdf

Mitrev, S. & Culpepper, R, 2012, ‘Expatriation in Europe: Factors and Insights’, The Journal of International Management Studies, vol.7, no.1, pp. 158-167.

Moses, C, Moore, K, Pleasant, J & Vest, D, 2011, ‘ADAPTING THE E.P.R.G PARADIGM TO INTERNATIONALIZING BUSINESS SCHOOLS: A CONCEPTUAL FRAMEWORK’, International Journal of Business and Social Science, vol. 2, no. 23, pp.60-67.

Moomaw, R., Olson, K., McLean, W. & Applegate, M 2009, Economics and Contemporary Issues (8th ed.). USA: Cengage Learning.

Nanda, S & Kumar, A, 2012, ‘International Staffing: Factors, Issues and alternatives’, Journal of Human Resource Management and Development (JHRMD), vol. 2, no. 2, pp. 56-64.

National Industry Program, 2016, the next phase: Opportunities in China's pharmaceuticals market, viewed 22 September 2016, https://www2.deloitte.com/content/dam/Deloitte/ch/Documents/life-sciences-health-care/ch_Studie_Pharmaceutical_China_05052014.pdf

Pacific Bridge Medical, 2014, China Regulatory and Market Access Pharmaceutical report. viewed 22 September 2016, https://www.pacificbridgemedical.com/wp-content/uploads/2015/04/China-Regulatory-and-Market-Access-Pharmaceutical-Report-2014.pdf  

Pharmaceutical & Life Sciences, 2016, Investing in China’s Pharmaceutical Industry, viewed 22 September 2016, https://www.pwc.com/gx/en/pharma-life-sciences/assets/en-pharma_03-26-small.pdf

Roncoroni, A., Fusai, G., & Cummins, M 2015, Handbook of Multi-Commodity Markets and Products: Structuring, Trading and Risk Management. USA: John Wiley & Sons.

Strategy&, 2014, Pharma Emerging Markets 2.0, viewed 22 September 2016, https://www.strategyand.pwc.com/media/file/Strategyand_Pharma-Emerging-Markets-2.0.pdf 

Thoo, L, 2013, ‘International HR Assignment in Recruiting and Selecting: Challenges, Failures and Best Practices’, International Journal of Human Resource Studies, vol. 3, no. 4, pp 143-158.

Xiong, Y., Yamada, T., & Terano, T., 2015, Comparison of different market making strategies for high frequency traders. In 2015 Winter Simulation Conference (WSC). pp. 324-335. IEEE.

Yates, M., 2015, 12 Challenges Big Pharma Faces in China. viewed 22 September 2016, https://webcache.googleusercontent.com/search?q=cache:https://social.eyeforpharma.com/column/12-challenges-big-pharma-faces-china&gws_rd=cr&ei=RL_jV9GzM4WajwOwybP4Ag